Personal information

Activities

Collapse all

Employment (10)

Hôpital Gui De Chauliac: Montpellier, FR

2017-11 to present | Fellowship (Neurosurgery)
Employment
Source: Self-asserted source
Kejia Teo

Humanitas Research Hospital: Rozzano, IT

2017-07 to present | Fellowship (Neurosurgery)
Employment
Source: Self-asserted source
Kejia Teo

National University Hospital: Singapore, SG

2015-09 to present | Associate Consultant (Neurosurgery)
Employment
Source: Self-asserted source
Kejia Teo

National University Hospital: Singapore, SG

2011-05 to 2015-08 | Registrar (Neurosurgery)
Employment
Source: Self-asserted source
Kejia Teo

Queen's Hospital: Romford, London, GB

2013-08 to 2015-07 | Registrar (Neurosurgery)
Employment
Source: Self-asserted source
Kejia Teo

National University Hospital: Singapore, SG

2007-05 to 2011-04 | Medical Officer (General Surgery)
Employment
Source: Self-asserted source
Kejia Teo

Changi General Hospital: Singapore, SG

2010-05 to 2010-10 | Medical Officer (Orthopaedics)
Employment
Source: Self-asserted source
Kejia Teo

Changi General Hospital: Singapore, SG

2007-01 to 2007-05 | House Officer (General Medicine)
Employment
Source: Self-asserted source
Kejia Teo

Singapore General Hospital: Singapore, SG

2006-09 to 2006-12 | House Officer (Orthopedics)
Employment
Source: Self-asserted source
Kejia Teo

National University Hospital: Singapore, SG

2006-05 to 2006-08 | House Officer (Surgery)
Employment
Source: Self-asserted source
Kejia Teo

Education and qualifications (3)

Royal College of Surgeons of Edinburgh: Edinburgh, Edinburgh, GB

2010-06 to 2015-03 | FRCSEd (Neuro. Surg)
Education
Source: Self-asserted source
Kejia Teo

Royal College of Surgeons of Edinburgh: Edinburgh, Edinburgh, GB

2007-09 to 2010-05 | MRCS
Education
Source: Self-asserted source
Kejia Teo

National University of Singapore: Singapore, SG

2001-05 to 2006-05 | MBBS
Education
Source: Self-asserted source
Kejia Teo

Funding (1)

Use of suicide gene modified mesenchymal stem cells and 5-fluorocytosine prodrug for the targeted treatment of temozolomide resistant glioblastomas

2017-10 to 2018-09 | Grant
Singapore-MIT Alliance for Research and Technology - SMART (Singapore, SG)
GRANT_NUMBER: ING-000227 BIO IGN
Source: Self-asserted source
Kejia Teo
How many people are using ORCID?